Vyant Bio Inc

Formerly OTC: VYNT
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 16 pages Vyant Bio, Inc. and Sabine Brandt as Trustee for the Brandt Family Trust Share Purchase Agreement
12/34/56
EX-2.1
from 8-K 20 pages Vivopharm Pty Ltd and Sabine Brandt as Trustee for the Brandt Family Trust Share Purchase Agreement
12/34/56
EX-2.1
from 8-K 73 pages Dated November 2, 2022 Equity Purchase Agreement Among Reaction Biology Corporation, as Purchaser Vivopharm Pty, Ltd., as Seller Vyant Bio, Inc., as Parent and Vivopharm, LLC, as the Company
12/34/56
EX-2.1
from 8-K 7 pages Agreement
12/34/56
EX-2.1
from 425 7 pages Agreement
12/34/56
EX-2.1
from 425 14 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.1
from 8-K 14 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.1
from 425 111 pages Agreement and Plan of Merger and Reorganization Among: Cancer Genetics, Inc., a Delaware Corporation; Cgi Acquisition, Inc., a Minnesota Corporation; and Stemonix, Inc., a Minnesota Corporation Dated as of August 21, 2020
12/34/56
EX-2.1
from 8-K 111 pages Agreement and Plan of Merger and Reorganization Among: Cancer Genetics, Inc., a Delaware Corporation; Cgi Acquisition, Inc., a Minnesota Corporation; and Stemonix, Inc., a Minnesota Corporation Dated as of August 21, 2020
12/34/56
EX-2.1
from 10-Q 36 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 8-K 83 pages Secured Creditor Asset Purchase Agreement by and Among Interpace Biopharma, Inc. as the Buyer, Partners for Growth IV, L.P. as the Seller and Cancer Genetics, Inc. and Interpace Diagnostics Group, Inc. (Solely for Purposes of the Specified Sections) Dated as of July 15, 2019
12/34/56
EX-2.1
from 8-K 82 pages Agreement and Plan of Merger Among Cancer Genetics, Inc. Wogolos Ltd. and Novellusdx Ltd. Dated as of September 18, 2018
12/34/56
EX-2.1
from 425 82 pages Agreement and Plan of Merger Among Cancer Genetics, Inc. Wogolos Ltd. and Novellusdx Ltd. Dated as of September 18, 2018
12/34/56
EX-2.1
from 8-K 70 pages Stock Purchase Agreement Among Vivopharm Pty. Ltd. Brandt Family Trust South Australian Life Science Advancement Partnership, LP Royal Melbourne Institute of Technology Management Parties Selling Shareholders Cancer Genetics, Inc. and Dr. Ralf Brandt, as Shareholders’ Representative Dated as of August 14, 2017
12/34/56
EX-2
from SC 13G/A 2 pages Power of Attorney for Executing Schedules 13g and 13d, 13g/D Joint Filing Agreement and Form 13f
12/34/56